May 2019

May 17th, 2019

NIH administers first clinical trial treatment for GM1 created by Auburn, UMass

Milestone marks the first patient with GM1 gangliosidosis treated with gene therapy The first clinical trial of a gene therapy treatment created through a research alliance between Auburn University and the University of Massachusetts has been administered in a child at the National Institutes of Health, or NIH, in Bethesda, Maryland. The NIH clinical trial […]